Related Experiment Video
Updated: Mar 24, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
[CARDIOVASCULAR INVOLVEMENTS IN BEHÇET'S DISEASE: "ANGIO-BEHÇET"]
Insights
Behçet's disease is an immune-mediated vasculitis affecting blood vessels. Early recognition of its cardiovascular manifestations (angio-Behçet) is crucial for timely treatment and improved outcomes.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Context:
- Behçet's disease is a systemic vasculitis with unclear etiology.
- Diagnosis relies on clinical manifestations due to lack of specific biomarkers.
- Cardiovascular involvement (angio-Behçet) affects up to 40% of patients, typically young males.
Purpose:
- To describe the spectrum of cardiovascular manifestations in Behçet's disease.
- To enhance the detection and therapeutic management of angio-Behçet.
- To provide a comprehensive overview for clinicians.
Summary:
- Behçet's disease involves immune-mediated inflammation of blood vessels.
- Cardiovascular complications, or angio-Behçet, are common and present polymorphously.
- Early immunosuppressive and anticoagulant therapies are vital for clinical improvement.
Impact:
- Optimizing the early detection of cardiovascular involvement in Behçet's disease.
- Improving therapeutic strategies for angio-Behçet.
- Reducing diagnostic delays and enhancing patient outcomes.
Abstract:
Behçet's disease is a relapsing, immune-mediated systemic vasculitis that may affect blood vessels of all types and sizes. Nowadays, the etiology remains unclear. In the absence of a biological marker or pathognomonic radiology, the diagnosis is mainly based on clinical manifestations. The cardiovascular involvement, known as "angio-Behçet", is relatively common and affects up to 40% of patients. It typi- cally occurs in a young male, usually during the onset of the disease. In general, immunosuppressive and anticoagulant therapies initiated early are likely to induce a remarkable cli- nical improvement. Nevertheless, prompt recognition of the polymorphous cardiovascular manifestations of the disease is challenging and may be responsible for some considerable delay prior to initiation of adequate therapy. The aim of this article is to describe the spectrum of cardiovascular involve- ments of Behçet's disease in order to optimize detection and therapeutic management.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pericarditis I: Introduction